Frazier Life Sciences

Frazier Life Sciences accounts for 21 tracked companies with verified cap-table data, 21 of which disclose round sizes totalling $4B. The median disclosed raise is $180M, and the largest is Angitia Biopharmaceuticals at $406M, ahead of Alentis Therapeutics ($366M) and Aspen Neuroscience ($340M).

The names that recur most often on these portfolio cap tables are Frazier Life Sciences (21 companies), OrbiMed (6 companies), RA Capital Management (6 companies), Deep Track Capital (4 companies), Janus Henderson Investors (3 companies), Longitude Capital (3 companies). By latest disclosed round, the market skews Series A (8), Series B (6), Series C (3), Series D (2).

• Companies tracked: 21
• Disclosed funding total: $4B across 21 companies
• Median disclosed raise: $180M
• Largest raise: Angitia Biopharmaceuticals — $406M
• Stage mix: Series A 8 · Series B 6 · Series C 3 · Series D 2
• Most recent dated round: 2026-05-20

Best funded Frazier Life Sciences companies

1. Angitia Biopharmaceuticals — $406M (latest: Series D)
2. Alentis Therapeutics — $366M (latest: Series D)
3. Aspen Neuroscience — $340M (latest: Series C)
4. Axon Neurosciences — $340M (latest: Series C)
5. Metagenomi — $300M (latest: Series B)
6. Diagonal Therapeutics — $253M (latest: Series B)
7. AirNexis Therapeutics — $200M (latest: Series A)
8. Braveheart Bio — $190M (latest: Series A)
9. Sudo Biosciences — $188M (latest: Series B)
10. Callio Therapeutics — $187M (latest: Series A)
11. cAMPfield Therapeutics — $180M (latest: Series A)
12. Sidewinder Therapeutics — $162M (latest: Series B)
13. Eyconis — $150M
14. HilleVax — $135M (latest: IPO)
15. Silence Therapeutics — $120M (latest: Series B)

Frazier Life Sciences — related firms and companies (56)

• Angitia Biopharmaceuticals
• Alentis Therapeutics
• Aspen Neuroscience
• Axon Neurosciences
• Metagenomi
• Diagonal Therapeutics
• AirNexis Therapeutics
• Braveheart Bio
• Investors like Maveron
• Investors like Contour Venture Partners
• Investors like Sofinnova Investments
• Investors like BoxGroup
• Investors like Upfront Ventures
• Callio Therapeutics
• Silence Therapeutics
• Alesta Therapeutics
• Investors like GIC
• Investors like Battery Ventures
• Investors like Flybridge
• Investors like ACME Capital
• Investors like StepStone Group
• Investors like Balderton Capital
• Investors like Menlo Ventures
• Investors like Madrona
• Eyconis
• Radionetics Oncology
• Investors like Frazier Life Sciences
• Investors like Plug and Play
• Investors like Matrix
• Investors like International Finance Corporation
• Investors like Acre Venture Partners
• Investors like Bond
• Investors like First Round Capital
• Investors like Founder Collective
• cAMPfield Therapeutics
• Vima Therapeutics
• 35Pharma
• Investors like Zetta Venture Partners
• Investors like Draper Associates
• Investors like IVP
• Investors like Techstars Ventures
• Investors like Maven Ventures
• Investors like Sequoia Capital
• Investors like Spark Capital
• Sudo Biosciences
• HilleVax
• Hillstar Bio
• Companies backed by Frazier Life Sciences
• Investors like Insight Partners
• Investors like Wellington Management
• Investors like Franklin Templeton
• Investors like Amplify Partners
• Investors like Oak HC/FT
• Investors like Felicis
• Investors like Polaris Partners
• Sidewinder Therapeutics

Frazier Life Sciences alternatives · All research reports